Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tetra Bio-Pharma Inc (OP: TBPMF )

0.0115 +0.0005 (+4.55%)
Streaming Delayed Price Updated: 1:52 PM EDT, Jun 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,600
Open 0.0110
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0110
Today's Range 0.0110 - 0.0116
52wk Range 0.0009 - 0.1000
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Tetra Bio-Pharma Receives Funding from the Government of Canada for ARDS-003
The Company is receiving up to $150,000 in funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to support the development of its novel oral... 
Via TheNewswire.com
Exposures COVID-19
Tetra Bio-Pharma Inc. Announces a Delay in Filing 2022 Annual Financial Statements and Related Management's Discussion and Analysis
MONTREAL, QUEBEC – TheNewswire – March 1, 2023 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTC-PINK: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and... 
Via TheNewswire.com

Performance

YTD
-42.50%
-42.50%
1 Month
-22.30%
-22.30%
3 Month
-47.73%
-47.73%
6 Month
-43.07%
-43.07%
1 Year
-77.00%
-77.00%

More News

Read More
AI Study: Synthetic Cannabinoid + Favipiravir Presents Viable Treatment Against Viral Infections, Including COVID
Via Benzinga
Tetra Bio-Pharma Announces Second Closing Of Financing With Alpha Blue Ocean
Via Benzinga
Akanda To Supply Tetra Bio-Pharma With Cannabis For FDA Trials Of Cancer-Pain Drug
Via Benzinga
Preclinical Trial Results Confirm Targeting Type 2 Cannabinoid Receptors Helps Relieve Sepsis-Related Condition
Via Benzinga
Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription Drug
From Akanda Corp. and Tetra Bio-Pharma
Via Business Wire
Tetra Bio-Pharma Opens New Subsidiary In Australia And Provides Regulatory Update
Via Benzinga
Tetra Bio-Pharma Receives EMA Orphan Drug Designation For A Novel Topical Therapeutic Containing CBD
Via Benzinga
Tetra Bio-Pharma And Cannvalate Enter Into Partnership
Via Benzinga
Tetra Bio-Pharma Gets Health Canada's Approval To Use 100mg Of CBD In Inhaled Cannabidiol Safety Study
Via Benzinga
Tetra Bio-Pharma Signs License Agreement With Thorne Health Tech For A Prebiotic Dietary Supplement
Via Benzinga
Psychedelic & Marijuana Drug Stocks Continued To Decline Last Week
Via Talk Markets
Tetra Bio-Pharma Gets CA$4.5M From Québec's Government To Develop Medicine For ARDS
Via Benzinga
Tetra Bio-Pharma & Avicanna Enter Into Strategic Partnership
Via Benzinga
Psychedelic And Cannabis Drug Stocks Continue Advance
Via Talk Markets
Cannabis Stock Gainers And Losers From January 19, 2022
Via Benzinga
Cannabis Stock Gainers And Losers From January 18, 2022
Via Benzinga
Marijuana & Psychedelic Drug Stocks Continue To Decline
Via Talk Markets
Cannabis Stock Gainers And Losers From January 5, 2022
Via Benzinga
Cannabis Stock Gainers And Losers From January 4, 2022
Via Benzinga
Marijuana & Psychedelic Compounds-Based Drug Stocks Now Down -16% YTD
Via Talk Markets
Tetra Bio-Pharma: Positive Clinical Data From Both Phase 2 Clinical Trials Of QIXLEEF For Cancer Pain
Via Benzinga
Cannabis Drug Stocks Have Mirrored Performance Of Psychedelic Drug Stocks To Date In September
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Marijuana Drug Stocks: All You Need To Know Is Here!
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.